ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 147 out of 387

$503K Total Retail Price of All Prescriptions

Rank: 145 out of 387

340 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 6,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
METFORMIN HCL 346 301 1 8
SIMVASTATIN 251 242 2 5
HYDROCODONE-ACETAMINOPHEN 248 194 S3 3 1
LISINOPRIL 238 227 4 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 235 191 5 30
GABAPENTIN 219 155 6 10
LEVOTHYROXINE SODIUM 200 181 7 2
OMEPRAZOLE 180 147 8 4
DONEPEZIL HCL 166 166 9 27
PRAVASTATIN SODIUM 145 132 10 15
TAMSULOSIN HCL 127 117 11 32
ATORVASTATIN CALCIUM 124 109 12 13
MELOXICAM 121 117 13 22
METOPROLOL TARTRATE 118 111 14 11
SERTRALINE HCL 115 114 15 23
NAMENDA 113 113 16 35
DILTIAZEM 24HR CD 113 113 16 118
ALLOPURINOL 107 97 18 28
POTASSIUM CHLORIDE 107 106 18 9
ATENOLOL 102 98 20 20
FINASTERIDE 100 90 21 95
CLOPIDOGREL 96 94 22 25
PANTOPRAZOLE SODIUM 90 87 23 48
LOSARTAN POTASSIUM 88 72 24 24
CARVEDILOL 77 72 25 21
NEXIUM 72 67 26 26
ZOLPIDEM TARTRATE 71 48 27 16
TRAMADOL HCL-ACETAMINOPHEN 70 66 28 180
GLIMEPIRIDE 68 52 29 50
FUROSEMIDE 66 66 30 7
LOSARTAN-HYDROCHLOROTHIAZIDE 65 64 31 65
METOPROLOL SUCCINATE 65 64 31 18
LEVEMIR FLEXPEN 64 37 33 199
LANTUS 62 55 34 51
PLAVIX 61 60 35 39
JANUVIA 60 54 36 60
TORSEMIDE 59 55 37 132
DIOVAN HCT 59 59 37 74
VERAPAMIL ER 58 58 39 87
TRIAMTERENE-HCTZ 56 56 40 55
CITALOPRAM HBR 55 52 41 19
SYNTHROID 55 55 41 68
ETODOLAC 54 53 43 183
TRAMADOL HCL 52 47 44 14
GLYBURIDE 51 51 R 45 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.